Brian Schwartz
Hoofd Techniek/Wetenschap/O&O bij INTENSITY THERAPEUTICS, INC.
Vermogen: 46 596 $ op 31-05-2024
Actieve functies van Brian Schwartz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Directeur/Bestuurslid | 01-12-2020 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 17-12-2020 | - |
| Hoofd Techniek/Wetenschap/O&O | 25-01-2024 | - | |
| Independent Dir/Board Member | 17-12-2020 | 25-01-2024 | |
| INTENSITY THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Brian Schwartz
Eerdere bekende functies van Brian Schwartz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 07-09-2021 | 24-07-2023 |
| MEREO BIOPHARMA GROUP PLC | Directeur/Bestuurslid | 01-10-2020 | 10-11-2022 |
| VINCERX PHARMA, INC. | Directeur/Bestuurslid | 05-03-2020 | 23-12-2020 |
| Independent Dir/Board Member | 05-03-2020 | 23-12-2020 | |
| ARQULE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2008 | 01-03-2020 |
| ALAUNOS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | - |
| Algemeen Adviseur | 01-01-2008 | - |
Opleiding van Brian Schwartz
| University of Pretoria | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Zuid-Afrika | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 6 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
- Beurs
- Insiders
- Brian Schwartz
- Ervaring
